We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
(+4.7%)
Cap. Flow
-$10.1M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$4.11M |
| 2 |
Pool Corp
POOL
|
+$4M |
| 3 |
Estee Lauder
EL
|
+$3.62M |
| 4 |
Salesforce
CRM
|
+$2.95M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$2.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$5.48M |
| 2 |
D.R. Horton
DHI
|
+$4.76M |
| 3 |
Cisco
CSCO
|
+$4.46M |
| 4 |
Constellation Brands
STZ
|
+$4.2M |
| 5 |
Quest Diagnostics
DGX
|
+$1.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.18% |
| 2 | Healthcare | 10.11% |
| 3 | Financials | 8.69% |
| 4 | Consumer Discretionary | 6.97% |
| 5 | Industrials | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Morgan Stanley
MS
$333B
| $240K | 0.03% |
2,812
-621
| -18% | -$53.1K |
|
227
Texas Instruments
TXN
$253B
| $240K | 0.03% |
1,332
-226
| -15% | -$38.9K |
|
228
Dominion Energy
D
$62.1B
| $239K | 0.03% |
4,624
-600
| -11% | -$32.6K |
|
229
iShares MSCI USA Quality Factor ETF
QUAL
$46.2B
| $238K | 0.03% |
1,763
+6
| +0.3% | +$763 |
|
230
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
| $237K | 0.03% |
2,210
-761
| -26% | -$76.6K |
|
231
Qualcomm
QCOM
$172B
| $237K | 0.03% |
1,992
-403
| -17% | -$46.3K |
|
232
McCormick & Company Non-Voting
MKC
$13.9B
| $233K | 0.02% |
2,669
-160
| -6% | -$14.1K |
|
233
Yum! Brands
YUM
$41.4B
| $232K | 0.02% |
1,677
| – | – |
|
234
Avantis US Small Cap Value ETF
AVUV
$30.5B
| $231K | 0.02% |
+2,980
| New | +$219K |
|
235
Dimensional Emerging Core Equity Market ETF
DFAE
$9.1B
| $229K | 0.02% |
+9,749
| New | +$225K |
|
236
Nucor
NUE
$60.5B
| $228K | 0.02% |
1,388
| – | – |
|
237
Cardinal Health
CAH
$54.5B
| $227K | 0.02% |
+2,403
| New | +$203K |
|
238
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $227K | 0.02% |
2,994
-808
| -21% | -$61.4K |
|
239
Gilead Sciences
GILD
$167B
| $224K | 0.02% |
2,909
-72
| -2% | -$5.74K |
|
240
American Water Works
AWK
$27B
| $221K | 0.02% |
1,548
+71
| +5% | +$10.4K |
|
241
iShares Core US Aggregate Bond ETF
AGG
$138B
| $221K | 0.02% |
2,254
+26
| +1% | +$2.57K |
|
242
Realty Income
O
$61.3B
| $217K | 0.02% |
3,633
-571
| -14% | -$34.8K |
|
243
Metallus
MTUS
$879M
| $216K | 0.02% |
10,000
| – | – |
|
244
Danaher
DHR
$140B
| $213K | 0.02% |
1,003
-178
| -15% | -$37.7K |
|
245
DuPont de Nemours
DD
$19B
| $210K | 0.02% |
2,340
| – | – |
|
246
Emerson Electric
EMR
$85B
| $209K | 0.02% |
+2,317
| New | +$195K |
|
|
BNY
247
Bank of New York Mellon
BNY
$106B
| $206K | 0.02% |
4,626
-506
| -10% | -$21.7K |
|
248
Harley-Davidson
HOG
$2.66B
| $206K | 0.02% |
5,837
-30
| -0.5% | -$1.05K |
|
249
Seagate
STX
$169B
| $204K | 0.02% |
3,296
-7,015
| -68% | -$428K |
|
250
Kimberly-Clark
KMB
$37.5B
| $204K | 0.02% |
+1,476
| New | +$205K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
- Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
- Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
- Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
- Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
- Girard Partners opened 13 new positions and closed 13 in Q2 2023.
- Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.
Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.